HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noritaka Oyama Selected Research

Lichen Sclerosus et Atrophicus (Lichen Sclerosus)

11/2020Gene silencing of extracellular matrix protein 1 (ECM1) results in phenotypic alterations of dermal fibroblasts reminiscent of clinical features of lichen sclerosus.
8/2010Lichen sclerosus et atrophicus-like skin lesions in a patient carrying a novel hydroxymethylbilane synthase mutation.
12/2009A case of lichen sclerosus of the scalp associated with autoantibodies to extracellular matrix protein 1.
6/2004Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
7/2003Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noritaka Oyama Research Topics

Disease

7Psoriasis (Pustulosis Palmaris et Plantaris)
06/2021 - 09/2002
5Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
11/2020 - 07/2003
4Fibrosis (Cirrhosis)
01/2022 - 01/2018
4Systemic Scleroderma (Systemic Sclerosis)
10/2020 - 05/2012
4Atopic Dermatitis (Atopic Eczema)
11/2006 - 11/2002
2Interstitial Lung Diseases (Interstitial Lung Disease)
10/2020 - 05/2012
2Candidiasis (Moniliasis)
04/2020 - 07/2017
2Neoplasms (Cancer)
11/2017 - 10/2008
2Sclerosis
05/2012 - 03/2012
2Skin Diseases (Skin Disease)
11/2006 - 06/2004
2Genetic Predisposition to Disease (Genetic Predisposition)
09/2006 - 07/2006
2Poikiloderma of Kindler
01/2004 - 07/2003
1Amelanotic Melanoma (Amelanotic Melanomas)
06/2021
1Hidradenitis Suppurativa
06/2021
1Necrosis
02/2021
1Pulmonary Arterial Hypertension
10/2020
1Disease Progression
10/2020
1Tuberculosis (Tuberculoses)
09/2020
1Ulcerative Colitis
09/2020
1Erythema Induratum (Bazin Disease)
09/2020
1Vulvovaginal Candidiasis
04/2020
1Inflammation (Inflammations)
11/2019
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
11/2019
1Airway Obstruction (Choking)
01/2018
1Immune Reconstitution Inflammatory Syndrome
01/2018
1Erythema Multiforme
01/2018
1Exanthema (Rash)
01/2018
1Leukemia
01/2018
1Melanoma (Melanoma, Malignant)
01/2018
1Rare Diseases (Rare Disease)
11/2017
1Linear IgA Bullous Dermatosis
11/2017
1Heart Failure
07/2017
1Diarrhea
07/2017
1Rheumatoid Arthritis
06/2017
1Cysts
04/2017
1Granuloma
04/2017
1Parakeratosis
01/2017
1Blister (Bulla)
11/2016
1Autoimmune Diseases (Autoimmune Disease)
11/2016
1Pemphigus (Pemphigus Vulgaris)
11/2016
1Adenocarcinoma of Lung
06/2012

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
01/2022 - 09/2002
5Extracellular Matrix ProteinsIBA
11/2020 - 07/2003
5Proteins (Proteins, Gene)FDA Link
10/2008 - 07/2003
4AntigensIBA
01/2018 - 06/2004
4AutoantibodiesIBA
11/2017 - 07/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 09/2002
3Glycoproteins (Glycoprotein)IBA
11/2016 - 06/2004
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 01/2018
2EnzymesIBA
02/2021 - 06/2005
2ChemokinesIBA
10/2020 - 06/2004
2Soaps (Soap)IBA
04/2020 - 07/2017
2Miconazole (Monistat)FDA LinkGeneric
04/2020 - 07/2017
2Transcription Factors (Transcription Factor)IBA
01/2018 - 10/2008
2Pharmaceutical PreparationsIBA
11/2017 - 01/2004
2AntibodiesIBA
11/2017 - 11/2016
2AutoantigensIBA
11/2017 - 07/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2005
2Interleukin-12 (IL 12)IBA
01/2011 - 07/2006
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2006 - 09/2002
2Immunoglobulin G (IgG)IBA
06/2004 - 07/2003
1brodalumabIBA
06/2021
1Lipase (Acid Lipase)FDA Link
02/2021
1Pancreatic Elastase (Elastase)IBA
02/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2020
1pro-brain natriuretic peptide (1-76)IBA
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
10/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020
1Antifungal AgentsIBA
04/2020
1Connective Tissue Growth FactorIBA
11/2019
1Monoclonal AntibodiesIBA
11/2019
1Niacinamide (Nicotinamide)FDA LinkGeneric
11/2019
1ArginaseIBA
01/2018
1IpilimumabIBA
01/2018
1NivolumabIBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2018
1CollagenIBA
01/2018
1Factor V (Coagulation Factor V)IBA
01/2018
1N-(3-pyridylmethyl)adriamycin (YM 1)IBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Collagen Type VIIIBA
11/2017
1Immunoglobulin A (IgA)IBA
11/2017
1Certolizumab PegolFDA Link
06/2017
1CholesterolIBA
04/2017
1Deoxyribonuclease I (Nickase)IBA
01/2017
1Deoxyribonucleases (DNase)FDA Link
01/2017
1mizoribineIBA
11/2016
1Desmoglein 3IBA
11/2016
1Tyrosine Kinase InhibitorsIBA
06/2012
1ErbB Receptors (EGF Receptor)IBA
06/2012
1Endothelin Receptor AntagonistsIBA
05/2012

Therapy/Procedure

3Therapeutics
09/2020 - 11/2011
2Oral Administration
01/2022 - 01/2018
1Rejuvenation
06/2021
1Skin Care
04/2020
1Subcutaneous Injections
11/2019
1Home Nursing (Nursing, Home)
07/2017
1Molecular Targeted Therapy
06/2012